Related Experiment Video
Updated: Aug 29, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Kawasaki disease
1Empire General Life Assurance Corporation, PO Box 310, Shawnee Mission, KS 66201-0310, USA.
Insights
Kawasaki disease is a leading cause of acquired heart disease in children. This review examines its pathogenesis, complications, treatment, and prognosis using an 18-year-old case study.
Area of Science:
- Pediatric Cardiology
- Immunology
Background:
- Kawasaki disease is the primary cause of acquired heart disease in children in the US and Japan.
- Early diagnosis and treatment are crucial to prevent cardiac complications.
Observation:
- Presents a case study of an 18-year-old insurance applicant with Kawasaki disease.
- Highlights the long-term implications of the disorder.
Findings:
- Reviews the pathogenesis, detailing the inflammatory processes involved.
- Discusses common and rare complications, including coronary artery aneurysms.
- Outlines current treatment strategies and their effectiveness.
Implications:
- Emphasizes the importance of understanding Kawasaki disease for long-term patient management.
- Informs prognosis and risk stratification for affected individuals.
- Underscores the need for continued research into Kawasaki disease etiology and treatment.
Abstract:
Kawasaki disease is currently the leading cause of acquired heart disease in children in the United States and Japan. The case of an 18-year-old insurance applicant is used to review the pathogenesis, complications, treatment and prognostic implications of this disorder.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Cytomegalovirus Disease
Rocky Mountain Spotted Fever
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...